Talecris Biotherapeutics Holding Corp. Merger Litigation

Law Office of Brodsky & Smith, LLC Announces Investigation of Talecris Biotherapeutics Holding Corp.  
 
BALA CYNWYD – (BUSINESS WIRE) Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Talecris Biotherapeutics Holding Corp. (“Talecris” or the “Company”) (Nasdaq: TLCR – News) relating to the proposed acquisition of Talecris by Grifols S.A. (“Grifols”). Under the terms of the agreement, Talecris shareholders would receive $19.00 in cash and 0.641 newly-issued non-voting Grifols’ shares for each share of Talecris common stock they own.  
 
The investigation concerns possible breaches of fiduciary duty and other violations of state law related to the Talecris board’s approval of the proposed transaction. The transaction appears to be unfair, in part, given that Talecris stock was trading at $24.12 a share as recently as February 2, 2010 and an analyst placed a $30 per share price target on Talecris. 
 
If you own shares of Talecris and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, or by calling toll free 877-LEGAL-90. 

To Join the Talecris Biotherapeutics Holding Corp. Litigation

1. Fill out this form

   Mr/Mrs/Ms --Select a title-- Mr. Mrs. Ms.

   First Name: Required

   Last Name:Required

   
   

   Address: Required

   City: Required

   State: Required Select a State AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY

   
   

   Email Address:Required

   Phone Number:Required

   
   

   Number of Shares Owned:Required

   Date purchased:

   
   

   By clicking on the submit button, I acknowledge that I have downloaded and read both the Merger Class Action Lawsuit Retainer Agreement and Class Representative Rights and Responsibilities documents, and agree to retain Brodsky & Smith, LLC to file an action against Talecris Biotherapeutics Holding Corp. in connection with this case. Brodsky & Smith, LLC will prosecute the action on a contingent fee basis and will advance all costs and expenses.
   

View Complaint

The complaint is unavailable at this time

Join Other Cases

Frequently Asked Questions

 

Home : All cases : Report a Fraud

FAQ's : Attorneys : Practice Areas : Contact Us : Links : Disclaimer